- Home
- Archives
- 2026
- Vol. 1 Issue 3
- Article
Drug-Related Problems and Clinical Pharmacist Interventions in Post-Traumatic Diabetic Foot Gangrene with Renal Impairment: A Case Report
Authors
1 2 3 4 5 Department of Pharmacy Practice, BVV Sangha’s Hanagal Shri Kumareshwar College of Pharmacy, Bagalkote, Karnataka, India.
Article Information
- DOI
- No Doi
- Published In
- Year 2026 · Volume 1 · Issue 3
- Published Online
- September-December 2026
- Pages
- 12-17
- Article Type
- Case Report
- Check for updates
-
References
1. Senneville É, Albalawi Z, van Asten SA, Abbas ZG, Allison G, Aragón-Sánchez J, et al. IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF/IDSA 2023). Diabetes/Metabolism Research and Reviews. 2024;40(3):e3687. doi:10.1002/dmrr.3687
2. American Diabetes Association Professional Practice Committee. 12. Retinopathy, neuropathy, and foot care: Standards of Care in Diabetes—2025. Diabetes Care. 2025;48(Suppl 1):S252–S265. doi:10.2337/dc25-S012
3. Levin A, Ahmed SB, Carrero JJ, et al. Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns. Kidney International. 2024;105(4):684–701. doi:10.1016/j.kint.2023.10.016
4. Schultz L, Lowe TJ, Srinivasan A, Neilson D, Pugliese G. Economic impact of redundant antimicrobial therapy in US hospitals. Infection Control and Hospital Epidemiology. 2014;35(10):1229–1235. doi:10.1086/678066
5. American Diabetes Association Professional Practice Committee. 13. Older adults: Standards of Care in Diabetes—2025. Diabetes Care. 2025;48(Suppl 1):S266–S282. doi:10.2337/dc25-S013
6. Peled O, Vitzrabin Y, Beit Ner E, Lazaryan M, Berlin M, Barchel D, et al. Acceptance rate of clinical pharmacists’ recommendations: an ongoing journey for integration. Frontiers in Pharmacology. 2023;14:1253990. doi:10.3389/fphar.2023.1253990
2. American Diabetes Association Professional Practice Committee. 12. Retinopathy, neuropathy, and foot care: Standards of Care in Diabetes—2025. Diabetes Care. 2025;48(Suppl 1):S252–S265. doi:10.2337/dc25-S012
3. Levin A, Ahmed SB, Carrero JJ, et al. Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns. Kidney International. 2024;105(4):684–701. doi:10.1016/j.kint.2023.10.016
4. Schultz L, Lowe TJ, Srinivasan A, Neilson D, Pugliese G. Economic impact of redundant antimicrobial therapy in US hospitals. Infection Control and Hospital Epidemiology. 2014;35(10):1229–1235. doi:10.1086/678066
5. American Diabetes Association Professional Practice Committee. 13. Older adults: Standards of Care in Diabetes—2025. Diabetes Care. 2025;48(Suppl 1):S266–S282. doi:10.2337/dc25-S013
6. Peled O, Vitzrabin Y, Beit Ner E, Lazaryan M, Berlin M, Barchel D, et al. Acceptance rate of clinical pharmacists’ recommendations: an ongoing journey for integration. Frontiers in Pharmacology. 2023;14:1253990. doi:10.3389/fphar.2023.1253990
Related Articles in this Issue
Share Article
*Instagram doesn't support direct link sharing from web. Copy the link and share it in your Instagram story or post.